Rebecca Codde

Abstract A071: PSMA-specific CARTyrin T-stem cell memory therapy eliminates solid tumor in subcutaneous prostate cancer model

E. Ostertag, D. Shedlock, J. Smith, 2018, Oral Presentations - Proffered Abstracts.

B-Cell Maturation Antigen (BCMA)-Specific, CentyrinTM-Based, PiggyBacTM-Transposed CAR-T Memory Stem Cells Are Effective Against p53-/- and Patient-Derived Multiple Myeloma Tumors

Burton E. Barnett, R. Davis, E. Ostertag, 2017 .

A Novel Bcma-Specific, Centyrin-Based CAR-T Product for the Treatment of Multiple Myeloma

Burton E. Barnett, R. Mathur, S. Neelapu, 2016 .

120 P-MUC1C-ALLO1: An allogeneic car-t for multiple solid tumor indications

E. Ostertag, D. Shedlock, Maximilian Richter, 2020, Journal for ImmunoTherapy of Cancer.

123 P-MUC1C-ALLO1: A fully allogeneic stem cell memory T cell (TSCM) CAR-T therapy with broad potential in solid tumor

E. Ostertag, Yingying Zhao, D. Shedlock, 2021, Journal for ImmunoTherapy of Cancer.